Dabi Atlante Sa Inds.
⚠️ Moderate Risk
FEI: 3003478608 • Ribeirao Preto • BRAZIL
FEI Number
3003478608
Location
Ribeirao Preto
Country
BRAZILAddress
Av.Presidente Castelo Branco, , Ribeirao Preto, , Brazil
Moderate Risk
FDA Import Risk Assessment
This firm has a moderate history of FDA import refusals. Some attention may be warranted.
Statistics
Score Breakdown
How is this score calculated?
Proprietary Algorithm
- 40% Violation Severity — AI-assessed (1-10)
- 30% Refusal Volume — Logarithmic scale
- 20% Recency — Decays over 5 years
- 10% Frequency — Refusals per year
© ImportRefusal.com Original Analysis
Violation Summary
REGISTERED
It appears the device is subject to listing under 510(j) and the initial distributor has not registered as required by 21 CFR 807.20 (a)(5).
NOT LISTED
It appears the drug or device is not included in a list required by Section 510(j), or a notice or other information respecting it was not provided as required by section 510(j) or 510(k).
NO 510(K)
The article is subject to refusal of admission pursuant to Section 801(a)(3) in that it is a post 1976 device for which a Section 510(k)application does not appear to have been determined substantially equivalent or otherwise filed.
NON STD
The article is subject to refusal of admission pursuant to section 536(a) of the Federal Food, Drug, and Cosmetic Act (FFDCA) in that it appears to be an electronic product offered for importation into the United States which fails to comply with an applicable standard prescribed pursuant to section 534 of the FFDCA.
Refusal History
| Date | Product | Violations | Division |
|---|---|---|---|
| 7/19/2004 | 76KLCCHAIR WITH UNIT | Division of Southeast Imports (DSEI) | |
| 7/19/2004 | 76EHDUNIT, X-RAY, EXTRAORAL WITH TIMER | 47NON STD | Division of Southeast Imports (DSEI) |
| 7/19/2004 | 76EHDUNIT, X-RAY, EXTRAORAL WITH TIMER | 47NON STD | Division of Southeast Imports (DSEI) |
| 9/22/2003 | 76EHDUNIT, X-RAY, EXTRAORAL WITH TIMER | Florida District Office (FLA-DO) | |
| 9/22/2003 | 76KLCCHAIR WITH UNIT | Florida District Office (FLA-DO) | |
| 9/22/2003 | 76EHDUNIT, X-RAY, EXTRAORAL WITH TIMER | Florida District Office (FLA-DO) | |
| 7/25/2003 | 76EHDUNIT, X-RAY, EXTRAORAL WITH TIMER | Florida District Office (FLA-DO) | |
| 7/25/2003 | 76KLCCHAIR WITH UNIT | Florida District Office (FLA-DO) | |
| 7/25/2003 | 76EHDUNIT, X-RAY, EXTRAORAL WITH TIMER | Florida District Office (FLA-DO) | |
| 7/25/2003 | 76EJBHANDLE, INSTRUMENT, DENTAL | Florida District Office (FLA-DO) | |
| 10/2/2002 | 76EHDUNIT, X-RAY, EXTRAORAL WITH TIMER | Florida District Office (FLA-DO) | |
| 10/2/2002 | 76KLCCHAIR WITH UNIT | Florida District Office (FLA-DO) | |
| 10/2/2002 | 76EHDUNIT, X-RAY, EXTRAORAL WITH TIMER | Florida District Office (FLA-DO) | |
| 10/2/2002 | 76EJBHANDLE, INSTRUMENT, DENTAL | Florida District Office (FLA-DO) | |
| 5/2/2002 | 74DSFRECORDER, PAPER CHART | Florida District Office (FLA-DO) |
Frequently Asked Questions
What is Dabi Atlante Sa Inds.'s FDA import refusal history?
Dabi Atlante Sa Inds. (FEI: 3003478608) has 15 FDA import refusal record(s) in our database, spanning from 5/2/2002 to 7/19/2004.
What is an FEI number?
FEI stands for Firm Establishment Identifier. It's a unique number assigned by the FDA to identify establishments that manufacture, process, pack, or hold food, drugs, medical devices, or other FDA-regulated products. Dabi Atlante Sa Inds.'s FEI number is 3003478608.
What types of violations has Dabi Atlante Sa Inds. received?
Dabi Atlante Sa Inds. has been cited for 4 different violation type(s). Common FDA violations include adulteration (unsafe or unsanitary products), misbranding (incorrect or misleading labels), and regulatory non-compliance.
Where does this information about Dabi Atlante Sa Inds. come from?
All FDA import refusal data for Dabi Atlante Sa Inds. is sourced from the official FDA Data Dashboard (datadashboard.fda.gov), a public government database maintained by the U.S. Food and Drug Administration.
Data sourced from the FDA Data Dashboard, a public database maintained by the U.S. Food and Drug Administration.